デイリーニュース

WHO and South Korea met in Seoul on 28‑29 August 2024 for their second Strategic Dialogue, aligning priorities and strengthening a 75‑year health partnership.

The Netherlands will fund WHO with €500,000 in 2024, bringing total support to over €1.1 million, to advance climate-change and health programmes worldwide.

France pledges €24 million to WHO, including €4.5 million flexible funds, to support health emergencies, NCDs and other priority areas.

Theravance Biopharma agreed to be acquired by Zymeworks for $929 million plus a contingent payment.

Il Dong Pharmaceutical Group will attend Bio USA 2026 in San Diego (Feb 22‑25) to present its pipeline and seek partnering opportunities, including GLP‑1 programs for obesity and diabetes.

RF Bio invited Turkish dermatology and aesthetic medicine professionals to its Wonju headquarters to view production facilities, R&D, and quality systems.

The Incheon Together Step Center and Incheon Hill Hospital have signed a memorandum of understanding to build a community cooperation system for drug addiction prevention, treatment and rehabilitation, aiming to improve care access in Incheon.

Luxembourg signed a Strategic Partnership Framework with WHO’s Ministry of Development Cooperation and a multiyear health agreement on 20 Dec 2024, reaffirming support for WHO’s health mission.

A new platform brings together pharmacists and the Pharmacist Writers Association to publish poems and essays reflecting pharmacists' experiences, alongside a personal story of a longtime drug wholesaler.

Tara Sparks, set to start at Novo Nordisk in February 2025, spent her last days off watching the Eagles vs Chiefs Super Bowl with friends.

WHO and Saudi Arabia’s KSrelief signed agreements at the Riyadh International Humanitarian Forum to combat malaria, cholera, polio and improve care for displaced populations.

WHO and Switzerland have renewed their cooperation strategy for 2024‑2028, extending a partnership that began in 2013.